WHO ICTRP trial
Mitapivat in Membranopathies
CTIS2023-503271-24-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-503271-24-01 |
|---|---|
| Public title | Mitapivat in Membranopathies |
| Scientific title | Safety and efficacy of mitapivat sulfate in adult patients with erythrocyte membranopathies - SATISFY |
| Primary sponsor | Eurobloodnet Association |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use - (Phase IV): no |
| Countries | Denmark;Netherlands;Canada |
| Conditions | erythrocyte membranopathies MedDRA version: 20.0Level: LLTClassification code: 10015268Term: Erythrocytes abnormalSystem Organ Class: 10005329;Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15];MedDRA version: 20.0Level… |
| Interventions | Product Name: Pyrukynd 5 mg film-coated tablets,Product Code: PRD10061235,Pharmaceutical Form: FILM-COATED TABLET,Other descriptive name: AG-348,Strength: Mitapivat 5mg,Product Name: Pyrukynd 20 mg film-coated tablets,Product Code… |
| Registration date | Aug 23, 2023 |
| Target size | 25 |
| Secondary IDs | NCT05935202 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: